GPX4 and pancreatic ductal adenocarcinoma: There are reports suggesting that targeting the MCP-GPX4/HMGB1 axis effectively triggers immunogenic ferroptosis in pancreatic ductal adenocarcinoma (Li et al. 2024a, b).